Drug profile · INN
dexamethasone
NEOFORDEX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dexamethasone (NEOFORDEX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravitreal. Current US regulatory status: approved.
Key facts
INN dexamethasone
Brand NEOFORDEX
Route INTRAVITREAL
Formulation IMPLANT
ATC code H02AB02
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is dexamethasone?
dexamethasone (NEOFORDEX) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravitreal. Current US regulatory status: approved.
What is the brand name for dexamethasone?
NEOFORDEX is a marketed brand name for dexamethasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexamethasone?
dexamethasone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.